| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1426827-79-3 / 1516551-46-4 | (1alpha,8alpha,9beta)-Bicyclo[6.1.0]non-4-yn-9-ylmethyl 2,5-dioxo-1-pyrrolidinyl carbonate | C15H17NO5 |
| 1426944-49-1 | 9-Chloro-5,6,7,8-tetrahydro-N-[3-[methyl(phenylmethyl)amino]propyl]-2-acridinecarboxamide | C25H28ClN3O |
| 1426953-21-0 | Thailanstatin A | C28H41NO9 |
| 1426960-33-9 | MK 8876 | C32H24F2N4O5S |
| 1427001-89-5 | AMY-101 | C83H117N23O18S2 |
| 1427004-19-0 | 2,5-Dioxo-1-pyrrolidinyl 20-(11,12-didehydrodibenz[b,f]azocin-5(6H)-yl)-17,20-dioxo-4,7,10,13-tetraoxa-16-azaeicosanoate | C34H39N3O10 |
| 1427035-62-8 | 5-[11-Fluoro-6-(hydroxymethyl)-6H-pyrido[2',3':5,6][1,3]oxazino[3,4-a]indol-2-yl]-2-(4-fluorophenyl)-N-methyl-6-[methyl(methylsulfonyl)amino]-3-benzofurancarboxamide | C33H26F2N4O6S |
| 1427054-08-7 | 1,5-Bis(3-hydroxyphenyl)-3-pentanone | C17H18O3 |
| 1427054-10-1 | 1,5-Bis(2-bromo-5-hydroxyphenyl)-3-pentanone | C17H16Br2O3 |
| 1427195-20-7 | 4-(1-Fluoro-1-methylethyl)-5-pyrimidinemethanamine hydrochloride (1:1) | C8H12FN3.HCl |
| 1427195-26-3 | 4-(1-Fluoro-1-methylethyl)-5-pyrimidinecarbonitrile | C8H8FN3 |
| 1427316-55-9 | N,9-Diphenyl-9H-carbazol-2-amine | C24H18N2 |
| 1427316-58-2 | N-([1,1'-Biphenyl]-4-yl)-9-phenyl-9H-carbazol-2-amine | C30H22N2 |
| 1427325-66-3 | JWH-081 N-(5-Hydroxypentyl) | C25H25NO3 |
| 1427325-83-4 | JWH-250 5-Hydroxypentyl bromide | C22H25NO3 |
| 1427358-21-1 | 6-Fluoro-1H-indole-5-carbonitrile | C9H5FN2 |
| 1427400-88-1 | 4-Methyl-3-pyrrolidinemethanol | C6H13NO |
| 1427404-87-2 | 4-Bromopyrazolo[1,5-a]pyridine | C7H5BrN2 |
| 1427405-10-4 | 6-Chloro-7-methyl-1H-indazole | C8H7ClN2 |
| 1427409-40-2 | 4-Bromo-2-fluoro-6-methylbenzoic acid methyl ester | C9H8BrFO2 |
| 1427415-25-5 | Methyl 4-bromo-2-fluoro-6-methoxybenzoate | C9H8BrFO3 |
| 1427417-84-2 | 4-Chloro-7-methyl-1,3-benzodioxole | C8H7ClO2 |
| 1427420-85-6 | 7-Chloro-5-benzofurancarbonitrile | C9H4ClNO |
| 1427429-03-5 | Lansoprazole Impurity 34 | C16H14F3N3O3S |
| 1427429-75-1 | 2-(Bromomethyl)-3-fluoropyridine hydrobromide (1:1) | C6H5BrFN.HBr |
| 1427439-32-4 | 4-Bromo-2-chloro-3-fluorobenzonitrile | C7H2BrClFN |
| 1427446-97-6 | 5-Fluorobenzofuran-4-carbonitrile | C9H4FNO |
| 1427460-49-8 | Ethyl 3-(2-oxoimidazolidin-1-yl)benzoate | C12H14N2O3 |
| 1427460-96-5 | 7-Bromo-1H-indazole-5-carboxylic acid methyl ester | C9H7BrN2O2 |
| 1427467-46-6 | (2R)-2-Amino-8-nonenoic acid | C9H17NO2 |
| 1427475-12-4 | 5-Bromo-1H-1,2,4-triazole-3-carbonitrile | C3HBrN4 |
| 1427475-33-9 | 1,4-Dimethyl-1H-imidazol-5-amine hydrochloride | C5H9N3.HCl |
| 1427521-37-6 | JWH-210 4-Hydroxypentyl | C26H27NO2 |
| 1427521-38-7 | JWH-250 4-Hydroxypentyl | C22H25NO3 |
| 1427521-40-1 | JWH-210 5-Hydroxypentyl | C26H27NO2 |
| 1427587-32-3 | 1-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroquinolin-2(1H)-one | C16H22BNO3 |
| 1427701-11-8 | 6-Bromo-2-fluoro-3-(trifluoromethyl)pyridine | C6H2BrF4N |
| 1427782-89-5 | N-(5-Phenyl-2-pyridinyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]acetamide | C25H20N4O2S2 |
| 1428118-12-0 | tert-butyl (3S,5S)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate | C37H43FN2O5 |
| 1428118-39-1 | (alphaR)-alpha-Methyl-N-[3-[4-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethanamine hydrochloride (1:1) | C22H22F3N.HCl |
| 1428134-39-7 | L-Threonyl-L-alanyl-L-prolyl-L-valyl-L-prolyl-L-methionyl-L-prolyl-L-alpha-aspartyl-L-leucyl-L-lysyl-L-asparaginyl-L-valyl-L-lysyl-L-seryl-L-lysyl-L-isoleucylglycyl-L-seryl-L-threonyl-L-alpha-glutamyl-L-asparaginyl-L-leucyl-L-lysyl-L-histidyl-L-glutaminyl-L-prolylglycylglycylglycyl-L-lysine | C136H230N40O42S |
| 1428185-71-0 | (alphaR)-alpha-Methyl-N-[3-[4-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethanamine | C22H22F3N |
| 1428243-24-6 | (3R,4S)-4-ethyl-1,3-Pyrrolidinedicarboxylic acid 1-(phenylmethyl) ester | C15H19NO4 |
| 1428243-25-7 | (3R,4S)-4-Ethyl-1,3-pyrrolidinedicarboxylic acid 1-(phenylmethyl) ester compd. with (alphaR)-alpha-methyl-1-naphthalenemethanamine (1:1) | C15H19NO4.C12H13N |
| 1428243-26-8 | (3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester | C16H20BrNO3 |
| 1428243-27-9 | Upadacitinib Impurity 1 | C34H39N5O7S |
| 1428243-36-0 | (3R,4S)-1-((Benzyloxy)carbonyl)-4-methylpyrrolidine-3-carboxylic acid | C14H17NO4 |
| 1428243-69-9 | Upadacitinib Impurity 28 | C15H19NO4 |
| 1428243-71-3 | (3S,4R)-1-((Benzyloxy)carbonyl)-4-methylpyrrolidine-3-carboxylic acid | C14H17NO4 |
| 1428323-50-5 | 2',3,6'-Trifluoro-4''-(trans-4-propylcyclohexyl)-4-(trifluoromethoxy)-1,1':4',1''-terphenyl | C28H26F6O |